284 related articles for article (PubMed ID: 22823754)
1. Prevalence of diabetes in Asian Indians based on glycated hemoglobin and fasting and 2-H post-load (75-g) plasma glucose (CURES-120).
Nazir A; Papita R; Anbalagan VP; Anjana RM; Deepa M; Mohan V
Diabetes Technol Ther; 2012 Aug; 14(8):665-8. PubMed ID: 22823754
[TBL] [Abstract][Full Text] [Related]
2. A1C cut points to define various glucose intolerance groups in Asian Indians.
Mohan V; Vijayachandrika V; Gokulakrishnan K; Anjana RM; Ganesan A; Weber MB; Narayan KM
Diabetes Care; 2010 Mar; 33(3):515-9. PubMed ID: 19903752
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012.
Menke A; Casagrande S; Geiss L; Cowie CC
JAMA; 2015 Sep; 314(10):1021-9. PubMed ID: 26348752
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India.
Kumpatla S; Aravindalochanan V; Rajan R; Viswanathan V; Kapur A
Diabetes Res Clin Pract; 2013 Oct; 102(1):60-4. PubMed ID: 24035281
[TBL] [Abstract][Full Text] [Related]
5. Isolated HbA1c identifies a different subgroup of individuals with type 2 diabetes compared to fasting or post-challenge glucose in Asian Indians: The CARRS and MASALA studies.
Gujral UP; Prabhakaran D; Pradeepa R; Kandula NR; Kondal D; Deepa M; Zakai NA; Anjana RM; Rautela G; Mohan V; Narayan KMV; Tandon N; Kanaya AM
Diabetes Res Clin Pract; 2019 Jul; 153():93-102. PubMed ID: 31150721
[TBL] [Abstract][Full Text] [Related]
6. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
[TBL] [Abstract][Full Text] [Related]
7. Baseline level of 30-min plasma glucose is an independent predictor of incident diabetes among Asian Indians: analysis of two diabetes prevention programmes.
Chamukuttan S; Ram J; Nanditha A; Shetty AS; Sevick MA; Bergman M; Johnston DG; Ramachandran A
Diabetes Metab Res Rev; 2016 Oct; 32(7):762-767. PubMed ID: 26991329
[TBL] [Abstract][Full Text] [Related]
8. Comparison of A1C, fasting and 2-h post-load plasma glucose criteria to diagnose diabetes in Italian Caucasians.
Marini MA; Succurro E; Arturi F; Ruffo MF; Andreozzi F; Sciacqua A; Lauro R; Hribal ML; Perticone F; Sesti G
Nutr Metab Cardiovasc Dis; 2012 Jul; 22(7):561-6. PubMed ID: 21944738
[TBL] [Abstract][Full Text] [Related]
9. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.
Davidson MB; Schriger DL; Peters AL; Lorber B
JAMA; 1999 Apr; 281(13):1203-10. PubMed ID: 10199430
[TBL] [Abstract][Full Text] [Related]
10. Detection of abnormal glucose tolerance in Africans is improved by combining A1C with fasting glucose: the Africans in America Study.
Sumner AE; Thoreson CK; O'Connor MY; Ricks M; Chung ST; Tulloch-Reid MK; Lozier JN; Sacks DB
Diabetes Care; 2015 Feb; 38(2):213-9. PubMed ID: 25338926
[TBL] [Abstract][Full Text] [Related]
11. Association of A1C with cardiovascular disease and metabolic syndrome in Asian Indians with normal glucose tolerance.
Dilley J; Ganesan A; Deepa R; Deepa M; Sharada G; Williams OD; Mohan V
Diabetes Care; 2007 Jun; 30(6):1527-32. PubMed ID: 17351274
[TBL] [Abstract][Full Text] [Related]
12. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of hemoglobin A1c criteria to assess preoperative diabetes risk in cardiac surgery patients.
Gianchandani RY; Saberi S; Zrull CA; Patil PV; Jha L; Kling-Colson SC; Gandia KG; DuBois EC; Plunkett CD; Bodnar TW; Pop-Busui R
Diabetes Technol Ther; 2011 Dec; 13(12):1249-54. PubMed ID: 21854260
[TBL] [Abstract][Full Text] [Related]
14. Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study.
Mukai N; Doi Y; Ninomiya T; Hata J; Hirakawa Y; Fukuhara M; Iwase M; Kiyohara Y
Diabet Med; 2012 Jan; 29(1):99-106. PubMed ID: 21726278
[TBL] [Abstract][Full Text] [Related]
15. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes.
Colagiuri S; Lee CM; Wong TY; Balkau B; Shaw JE; Borch-Johnsen K;
Diabetes Care; 2011 Jan; 34(1):145-50. PubMed ID: 20978099
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria.
Rosella LC; Lebenbaum M; Fitzpatrick T; Zuk A; Booth GL
Diabetes Care; 2015 Jul; 38(7):1299-305. PubMed ID: 25852207
[TBL] [Abstract][Full Text] [Related]
17. Concordance of two diabetes diagnostic criteria using fasting plasma glucose and hemoglobin A1c: the Yuport Medical Checkup Centre study.
Inoue K; Kashima S; Ohara C; Matsumoto M; Akimoto K
PLoS One; 2012; 7(10):e47747. PubMed ID: 23082207
[TBL] [Abstract][Full Text] [Related]
18. Applicability of a combination of hemoglobin A(1c) and fasting plasma glucose in population-based prediabetes screening.
Okosun IS; Davis-Smith M; Paul Seale J; Ngulefac J
J Diabetes; 2012 Dec; 4(4):407-16. PubMed ID: 22268513
[TBL] [Abstract][Full Text] [Related]
19. Relationship between A1C and fasting plasma glucose in dysglycemia or type 2 diabetes: an analysis of baseline data from the ORIGIN trial.
Ramachandran A; Riddle MC; Kabali C; Gerstein HC;
Diabetes Care; 2012 Apr; 35(4):749-53. PubMed ID: 22323416
[TBL] [Abstract][Full Text] [Related]
20. Identifying Africans with undiagnosed diabetes: Fasting plasma glucose is similar to the hemoglobin A1C updated Atherosclerosis Risk in Communities diabetes prediction equation.
Mugeni R; Hormenu T; Hobabagabo A; Shoup EM; DuBose CW; Sumner AE; Horlyck-Romanovsky MF
Prim Care Diabetes; 2020 Oct; 14(5):501-507. PubMed ID: 32173292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
